A Child with Acute Encephalopathy Associated with Quadruple Viral Infection by Keiko Nakata et al.
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
PEDIATRICS
CLINICAL CASE STUDY
published: 02 April 2015
doi: 10.3389/fped.2015.00026
A child with acute encephalopathy associated with
quadruple viral infection
Keiko Nakata1, Mitsuru Kashiwagi 2, Midori Masuda2, Seiji Shigehara2, Chizu Oba2, Shinya Murata2,
Tetsuo Kase1 and JunA. Komano1,3*
1 Department of Infectious Diseases, Osaka Prefectural Institute of Public Health, Osaka, Japan
2 Department of Paediatrics, Hirakata City Hospital, Hirakata, Japan
3 Department of Clinical Laboratory, National Hospital Organization Nagoya Medical Center, Nagoya, Japan
Edited by:
John R. Mytinger, The Ohio State
University, USA
Reviewed by:
Vincenzo Salpietro, Chelsea and
Westminster Hospital, UK
Jonathan Robert Honegger, The Ohio
State University, USA
*Correspondence:
Jun A. Komano, National Hospital
Organization Nagoya Medical Center,
4-1-1 Sannomaru, Naka-ku, Nagoya
460-0001, Japan
e-mail: komano@nnh.hosp.go.jp
Pediatric acute encephalopathy (AE) was sometimes attributed to virus infection. However,
viral infection does not always result in AE.The risk factors for developing infantile AE upon
virus infection remain to be determined. Here, we report an infant with AE co-infected
with human herpesvirus-6 (HHV-6) and three picornaviruses, including coxsackievirus A6
(CVA6), Enterovirus D68 (EV-D68), and human parechovirus (HPeV). EV-D68 was vertically
transmitted to the infant from his mother. CVA6 and HPeV were likely transmitted to the
infant at the nursery school. HHV-6 might be re-activated in the patient. It remained unde-
termined, which pathogen played the central role in the AE pathogenesis. However, active,
simultaneous infection of four viruses should have evoked the cytokine storm, leading to
the pathogenesis of AE.Conclusion: an infant casewith active quadruple infection of poten-
tiallyAE-causing viruseswas seldom reported partly because systematic nucleic acid-based
laboratory tests on picornaviruses were not common.We propose that simultaneous viral
infection may serve as a risk factor for the development of AE.
Keywords: acute encephalopathy, coxsackievirus A6, enterovirus D68, human parechovirus, human herpesvirus-6,
risk factor, viral co-infection
INTRODUCTION
Acute encephalopathy (AE) is a neurological dysfunction that
presents with altered consciousness, sometimes associated with
neurological injury or death in young children (1, 2). Many eti-
ologic factors have been identified, including infectious agents
and genetic factors. AE in young children is often associated
with virus infection. The risk factors for developing infan-
tile AE upon virus infection remain to be determined because
infections with the aforementioned viruses usually cause mild
symptoms.
Acute encephalopathy in young children is often associated
with virus infection, including influenza virus (3–5), human
herpesvirus-6 (HHV-6) (6), rotavirus (7), mumps virus (8), and
human parechovirus (HPeV), a newly discovered virus of the
Picornavirus family (9). One of the most systematic etiologic stud-
ies on AE, in which 983 subjects were examined, was performed in
Japan during 2007–2010 (10). The three most frequently detected
pathogens were human influenza virus (HIFV, 26.6%), HHV-6
(17.0%), and rotavirus (4.0%). Other pathogens were respira-
tory syncytial virus (RSV), human adenovirus (HAdV), and HPeV.
Only five cases showed co-infection with two pathogens, such as
HHV-6 and RSV or rotavirus and Campylobacter jejuni. Etiology
was undetermined for approximately half of the infant AE cases.
Such a study has not been performed in developing countries.
Laboratory technology for detecting pathogens at the nucleic
acid level is advancing, and this may provide clues as to the etiology
of AE. Here, we describe an infant AE case that may provide
insights into this question.
BACKGROUND
PATIENT HISTORY
A previously healthy male infant aged 1 year and 9 months pre-
sented to a primary physician with fever (38.4°C). During a phys-
ical examination, the infant had a convulsive seizure accompanied
by flaccid paralysis of the limbs, upward tonic eye deviation, and
tachycardia (190 beats/min). The subject was admitted to an emer-
gency hospital. On arrival, the subject presented with high fever
(39.3°C) and status epilepticus (Figure 1).
LABORATORY EXAMINATION, IMAGING, AND
ELECTROENCEPHALOGRAPHY
Laboratory examinations revealed a white blood cell count of
19,060 cells/ml (neutrophils, 51.1%; lymphocytes, 43.4%; and
monocytes, 4.0%); red blood cell count of 4.42 million cells/ml;
and blood hemoglobin level of 9.5 g/dl. Most of the serum markers
remained within the normal range, including C-reactive protein
(CRP), total bilirubin (TB), creatine phosphokinase (CPK), blood
urine nitrogen (BUN), and creatinin. Serum levels of aspartate
aminotransferase (AST), alanine aminotransferase (ALT), and lac-
tate dehydrogenase (LDH) were slightly elevated. Blood sugar
was 240 mg/dl. Serum pro-inflammatory markers interleukin-6
(IL-6) and interleukin-1 beta (IL-1b) were 299 pg/ml (normal
range, <4.0 pg/ml) and 1.4 pg/ml (normal range, <10 pg/ml),
respectively. Cerebrospinal fluid (CSF) was colorless and trans-
parent. CSF glucose, blood cell count, and total protein were
within normal ranges. CSF IL-6 was 40 pg/ml, and IL-1b was
undetectable. A cranial computed tomography scan and magnetic
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FIGURE 1 | Clinical course of the presented subject and his family
history. The triangle indicates the day of specimen collection for the subject.
Detected pathogens were indicated above each triangle. Days post-onset
refer to the time-course of symptoms in the subject. Please see the main text
for details. Abbreviations: HHV-6, human herpesvirus type-6; EV68,
enterovirus 68; HPeV, human parechovirus; CVA6, coxsachievirus A6; MDZ,
midazolam; mPSL, methylpredonisolone; EDV, edaravone; RhV, rhinovirus;
and Echo18, echovirus 18.
resonance imaging of the brain without contrast showed no par-
ticular findings. An electroencephalogram demonstrated diffuse,
high-amplitude slow wave activity.
EXAMINATION OF INFECTIOUS AGENTS
The blood HHV-6 DNA load was 3× 102 copies/ml, but HHV-6
was not detected in CSF. The plasma titer for anti-HHV-6 IgG was
1:60, and IgM was undetectable.
Enterovirus species were further examined because of the
family history (detailed below) and a hand–foot–mouth dis-
ease (HFMD) outbreak in the nursery school where the subject
was attending. In addition, regional surveillance revealed HFMD
and herpangina outbreaks due to coxsackievirus A6 (CVA6) and
enterovirus 71 (EV71) infections. Nucleic acid-based examina-
tion and virus isolation tests in tissue culture and suckling mice
were performed (11). Enterovirus D68 (EV-D68) was detected in
throat swab and stool specimens. HPeV was also positive for RNA
extracted from the throat swab (12). Additionally, CVA6 was posi-
tive in the stool. A tissue culture-based virus isolation test detected
HPeV-1 from the stool specimen (13). In the suckling mice-based
virus isolation test, CVA6 was detected in stool specimen (14).
However, CVA6, EV71, and EV-D68 were not detected by nucleic
acid-based examination in CSF.
Beside these viruses, immunochromatographic tests were neg-
ative for rotavirus, HAdV, and RSV on admission. Nucleic
acid-based tests were negative for HHV-7, Japanese encephalitis
virus (JEV), vesicular stomatitis virus (VSV), and herpes simplex
virus type (HSV) in blood and CSF. Bacterial cultures from blood
and CSF were negative.
In summary, four viruses were detected: HHV-6 and three
picornavirus species, namely, EV68, HPeV-1, and CVA6 (Figure 1;
Table 1).
FAMILY HISTORY
Four days prior to onset of illness in the infant, his mother pre-
sented with cold symptoms. A day before and after the onset of
illness in the infant, his father and older sister, aged 3 years and
4 months, also presented cold symptoms. PCR-based laboratory
tests revealed that stool specimens from the mother were positive
for EV-D68. Three enterovirus species were detected from his older
sister: the stool specimen was positive for echovirus 18 (Echo18)
and the throat swab was positive for both HPeV and rhinovirus
(RhV). No virus was detected from the patient’s father (Figure 1;
Table 1).
DISCUSSION
DIAGNOSIS, TREATMENT, AND OUTCOME
The differential diagnosis included acute encephalitis, acute
meningitis, and non-infectious causes of AE such as toxic or
metabolic encephalopathy. We diagnosed this patient as AE
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Table 1 | Summary of viruses detected in the patient, his family, and
regional surveillance.
Subject Detected virus Specimen
Patient CAV A6 Stool
EV-D68 Throat swab, stool
HHV-6 Blood
HPeV Throat swab, stool
Mother EV-D68 Stool
Father Not detected –
Older sister Echo18 Stool
HPeV Throat swab, stool
RhV Throat swab
Regional surveillance CVA6 HFMD and herpangina patients
EV71 HFMD and herpangina patients
CAV, coxsackievirus; Echo18, echovirus 18; EV71, enterovirus 71; EV-D68,
enterovirusD68;HFMD, hand–foot–mouth disease; HHV-6, human herpesvirus-6;
HPeV, human parechovirus; RhV, rhinovirus.
associated with active infection of four viruses because of the low
inflammatory markers. The seizure lasted 52 min, and was stopped
by intramuscular administration of midazolam (0.22 mg/kg). The
subject was then administered mannitol infusion 1 g/kg, methyl-
prednisolone 30 mg/kg/day, and edaravone 1 mg/kg. Therapeu-
tic normothermia (36.0°C) for 12.5 h was also performed. One
day post-admission, the subject regained consciousness. However,
drowsiness remained until 7 days post-admission. No apparent
sequelae were recognized at discharge (Figure 1).
RISK FACTOR OF ACUTE ENCEPHALOPATHY
This is the first report of four potentially AE-causing viruses
detected in an infant with AE (15–18). The subject did not take
vaccine and travel abroad recently. The regional surveillance and
the family history suggest that EV-D68 was vertically transmitted
to the infant from his mother. Considering epidemiologic fac-
tors, CVA6 and HPeV were likely transmitted to the infant at the
nursery school. Thus, the infant had been infected with three picor-
naviruses at once. Given that none of the four viruses were found
in all of the specimens from the patients, their viral loads were
low compared with viral loads in primary mono-infections partly
because replication of the picornaviruses in vivo could have been
limited by viral interference (19). Regarding HHV-6, the viral load
was relatively low and viral DNA was not detected in the CSF.
In addition, plasma IgM against HHV-6 was undetectable. These
data indicate that HHV-6 has already established a latent infection
although the possibility of HHV-6 primary infection is not elim-
inated. Simultaneous co-infection with the three picornaviruses
could have damaged the immunity of this subject, leading to par-
tial immunosuppression. This might have triggered a reactivation
of latently infected HHV-6. The transient immunosuppressive
state with active infection of four viruses might have evoked a
physiological state akin to a so-called cytokine storm, which can
cause AE (1, 15, 20, 21). Thus, simultaneous infection of viruses
might be a risk factor for disease severity, most likely stemming
from picornavirus species. These hypotheses require experimental
verification in future studies.
CONCLUDING REMARKS
Picornavirus is often overlooked as an etiological factor for AE.
We successfully detected three picornaviruses because we carefully
monitored the regional surveillance data and used established,
systematized laboratory examination protocols. Laboratory tech-
nology to detect pathogens at the nucleic acid level is advancing,
and this may provide clues as to the etiology of AE.
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